The verified answer
As of Sep 2026, DEPLOY verifies Marsi Bionics: 2 models, 3 deployments across 1 region. 2 sources back the record.
CategoryExoskeletons
Overview
Marsi Bionics is a Spanish exoskeleton company founded in 2013 in Madrid, developing modular gait exoskeletons that give physically disabled people the freedom to stand and move. Products include pediatric and adult rehabilitation exoskeletons.
Verified record
- Verified deployments
- 3 deployments on file
- Active incidents
- None on file
Data & sources
Web sources
2
2 sources backing this record.View all →
Models (2)
View all models →Current platform
EXPLORER
Pediatric exoskeleton for children with mobility impairments.. Maturity: pilot. Maturity: pilot. It is a robotic system designed for physical AI applications. Key specifications include Form Factor: exoskeleton, Maturity: pilot.
Current platform
ATLAS 2030
Overground pediatric robotic gait training device, first wearable pediatric exoskeleton authorized for clinical use. Indicated for cerebral palsy and neuromuscular diseases.
Marsi Bionics on the deployment map
View the global map3 verified deployments across 1 region, newest verified Jun 2024. Explore where Marsi Bionics's robots are operating, by place and type.
View the full Marsi Bionics deployment record →
Relationships
Current leadership (1)
- Elena García Armada Co-founder & CEOsecondary-verified
Founders (1)
- Elena García Armadacofounder
Safety record
No incidents on record for Marsi Bionics.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Marsi Bionics3 deployments
Recent coverage
Marsi Bionics in third-party press
Peers
26 peers across 1 segment. Every Marsi Bionics competitor derived from shared form-factor and application-domain edges.
exoskeleton(26)
23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%
- ATOUNdirect competitor(inferred)moderate
- Againer Skidirect competitor(inferred)moderate
- B-TEMIAdirect competitor(inferred)moderate
- Bionik Laboratoriesdirect competitor(inferred)moderate
- Cyberdynedirect competitor(inferred)moderate
- Daiya Industry Co., Ltd.direct competitor(inferred)moderate
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- early
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
EXPLORER at Spain, Europe
- Deployment verifiedVerifiedJun 1, 2024
EXPLORER at Germany, Europe
- Deployment verifiedVerifiedJan 1, 2023
ATLAS 2030 at Madrid, Spain
Sources (2)
Common questions
What is Marsi Bionics?
What does Marsi Bionics make?
Is Marsi Bionics publicly traded?
Who competes with Marsi Bionics?
Who is the CEO of Marsi Bionics?
How can I invest in Marsi Bionics?
Where is Marsi Bionics headquartered?
Who owns Marsi Bionics?
Where does Marsi Bionics operate robots?
How many robots has Marsi Bionics deployed?
Is Marsi Bionics a top robotics company?
Is Marsi Bionics safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Marsi Bionics.Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Wandercraft3 models
- Ascentiz2 models
- DIH Medical2 models
In the press
Recent coverage mentioning Marsi Bionics from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /companies/marsi-bionics.md
- RSS feed: /companies/marsi-bionics/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/3ea85617-4a18-4c2d-915f-40e9b1bfb4a4
- Revision history: /companies/marsi-bionics/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Fourier Intelligence4 models
- Honda3 models
- Lockheed Martin3 models
- Wandercraft3 models
- Ascentiz2 models
- DIH Medical2 models
Video
Marsi Bionics anounces on May 2021 the ATLAS 2030 has received CE clearance for its use in EU rehabilitation centres and hospitals. It is the first wearable paediatric gait exoskeleton authorised for clinical use. Indica
The MAK is an active knee othesis used for neurological rehabilitation of the lower limb and for post surgery knee rehabilitation. It boosts the rehabilitation
Marsi Bionics anounces on May 2021 the ATLAS 2030 has received CE clearance for its use in EU rehabilitation centres and hospitals. It is the first wearable pae
Gait assistance knee exoskeleton for Stroke rehabilitation. Beta Version, entering clinical evaluation.
Marsi Bionics (a spin‐off from Spanish National Research Council, CSIC) is recognized as a high impact SME developing disruptive therapies to the healthcare sec
The ATLAS Exo is a groundbreaking robotic paediatric exoskeleton crafted for gait rehabilitation in children facing neurological or neuromuscular disorders. The
Some children never walked in their lives before #robotics #Startup Marsi Bionics. The company developed the only #exoskeleton in the world that allows a child
Jaziel arrived at Asociación Pro Personas por Parálisis Cerebral (APAC) with significant motor challenges and a great fear of movement, as David Cordero, head o
Healthcare professionals discuss the use of robotics in exoskeletons for neurological rehabilitation in children, as well as its impact and benefits, backed by
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Marsi Bionics draws attention at the 17th percentile but verifies reality at the 64th percentile among exoskeletons. Hype Gap -46.2, 42nd widest among exoskeletons.
6-month trend
Analysis
Clean safety record across 3 verified deployments. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026